Evidence map›Paper›PMID 35296278›Full record

ArticleBMC neurology2022

COVID-19 atypical Parsonage-Turner syndrome: a case report.

Maria Beatrice Zazzara, Anna Modoni, Alessandra Bizzarro, Alessandra Lauria, Francesca Ciciarello, Cristina Pais, Vincenzo Galluzzo, Francesco Landi, Matteo Tostato, Gemelli Against COVID-19 Post-Acute Care Team

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC neurology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 10 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Parsonage-Turner Syndrome After COVID-19 Vaccination in a Child.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2023
    Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Maria Beatrice ZazzaraDepartment of Gerontology, Neuroscience and Orthopedics, Fondazione Universitaria Policlinico Gemelli, IRCCS, Rome, Italy. mariabeatrice.zazzara@policlinicogemelli.it.ORCID http://orcid.org/0000-0001-9155-3388
Anna ModoniUnità Operativa Complessa Di Neurologia, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy.
Alessandra BizzarroDepartment of Gerontology, Neuroscience and Orthopedics, Fondazione Universitaria Policlinico Gemelli, IRCCS, Rome, Italy.
Alessandra LauriaDepartment of Gerontology, Neuroscience and Orthopedics, Fondazione Universitaria Policlinico Gemelli, IRCCS, Rome, Italy.
Francesca CiciarelloDepartment of Gerontology, Neuroscience and Orthopedics, Fondazione Universitaria Policlinico Gemelli, IRCCS, Rome, Italy.
Cristina PaisDepartment of Gerontology, Neuroscience and Orthopedics, Fondazione Universitaria Policlinico Gemelli, IRCCS, Rome, Italy.
Vincenzo GalluzzoDepartment of Gerontology, Neuroscience and Orthopedics, Fondazione Universitaria Policlinico Gemelli, IRCCS, Rome, Italy.
Francesco LandiDepartment of Gerontology, Neuroscience and Orthopedics, Fondazione Universitaria Policlinico Gemelli, IRCCS, Rome, Italy.
Matteo TostatoDepartment of Gerontology, Neuroscience and Orthopedics, Fondazione Universitaria Policlinico Gemelli, IRCCS, Rome, Italy.
Gemelli Against COVID-19 Post-Acute Care Team
Agostino Gemelli University Polyclinic · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundNeurological manifestations of Sars-CoV-2 infection have been described since March 2020 and include both central and peripheral nervous system manifestations. Neurological symptoms, such as headache or persistent loss of smell and taste, have also been documented in COVID-19 long-haulers. Moreover, long lasting fatigue, mild cognitive impairment and sleep disorders appear to be frequent long term neurological manifestations after hospitalization due to COVID-19. Less is known in relation to peripheral nerve injury related to Sars-CoV-2 infection. CASE PRESENTATION: We report the case of a 47-year-old female presenting with a unilateral chest pain radiating to the left arm lasting for more than two months after recovery from Sars-CoV-2 infection. After referral to our post-acute outpatient service for COVID-19 long haulers, she was diagnosed with a unilateral, atypical, pure sensory brachial plexus neuritis potentially related to COVID-19, which occurred during the acute phase of a mild Sars-CoV-2 infection and persisted for months after resolution of the infection.

conclusionsWe presented a case of atypical Parsonage-Turner syndrome potentially triggered by Sars-CoV-2 infection, with symptoms and repercussion lasting after viral clearance. A direct involvement of the virus remains uncertain, and the physiopathology is unclear. The treatment of COVID-19 and its long-term consequences represents a relatively new challenge for clinicians and health care providers. A multidisciplinary approach to following-up COVID-19 survivors is strongly advised.

Indexed as

Brachial Plexus NeuritisCOVID-19FemaleHumansMiddle AgedSARS-CoV-2Atypical brachial plexus neuritisCOVID-19 neurological manifestationsCOVID-19 neuromuscular sequelaeSars-CoV-2 infection

Identifiers

PMID35296278
PMCPMC8924565
OpenAlexW4220727033

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.